The previously announced investigation by Italian authorities into the supply of stolen medicines (Herceptin, Remicade and Alimta) has identified two additional products (Avastin and Mabthera) that have been distributed illegally from their territory.

A document is available that lists the batches of Alimta (pemetrexed), Avastin (bevacizumab), Herceptin (trastuzumab), Mabthera (rituximab) and Remicade (infliximab) concerned by the ongoing investigation into the theft of vials of these medicines in Italy, as announced by the European Medicines Agency on 16 and 17 April 2014.

 

Posted on the EMA website on 3 June 2014